- Poster presentation
- Open Access
The primary outcomes and power calculations in clinical RCTs in urogynecology - need for improvement?
© Koch et al; licensee BioMed Central Ltd. 2015
- Published: 29 May 2015
- Primary Outcome
- Secondary Outcome
- Quantification System
- Pelvic Organ Prolapse
- Power Calculation
Except for studies where composite outcomes are chosen, a randomized controlled trial must have a primary outcome parameter. The primary outcome must be unambiguous, reliably assessable and clinically relevant. The estimated difference between the primary outcome in the study and control group(s) is used for the power calculation to determine the number of subjects needed for the trial.
We reviewed all RCTs published in three urogynecology journals (International Urogynecology Journal – IUJ), Neurourology and Urodynamics - NAU, Female Pelvic Medicine and Reconstructive Surgery - FPMRS) and three general gynecology journals (Obstetrics and Gynecology - GREEN, American Journal of Obstetrics and Gynecology – AJOG, and BJOG – an International Journal of Obstetrics and Gynecology) in the field of Urogynecology in the year 2013.
The journals were hand searched for clinical randomized controlled trials, and the following variables were noted: type of primary outcome, number of secondary outcomes, power calculation.
Number of primary and secondary outcomes
> 1 primary outcome
mean secondary outcomes
The most common primary outcomes chosen by the investigators were results of questionnaires (n=8), and POPQ (pelvic organ prolapse quantification system) statements and bladder diaries (5 each).
Correct power calculations were done in 25/34 studies, and in 3 studies power calculation were reported in the methods section without giving the variable on which the power calculation was performed.
We conclude that there is room for improvement for authors and journals in regard to identification of primary outcomes and to correct power calculation in RCTs.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.